Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Sieć Badań nad Wdrażaniem Zmian Stylu Życia w Centrum Badawczym Prewencji (PRC) przy UMass Chan (LCIRN)

21 września 2026 zaktualizowane przez: Jamie Faro, University of Massachusetts, Worcester

Sieć Badawcza Implementacji Zmian Stylu Życia w PRC przy UMass Chan

The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.

Przegląd badań

Status

Rekrutacyjny

Warunki

Szczegółowy opis

This study will examine how a digital lifestyle change program (Noom) may support adults who have recently started taking GLP-1 medications, which are commonly prescribed for weight loss and blood sugar control. The goal is to better understand how structured lifestyle guidance may improve physical activity, nutrition, and overall health while people are using these medications.

A total of 220 adults will participate in the study. Participants will be randomly assigned to one of two groups. One group will receive a four-month digital lifestyle coaching program designed to support healthy eating, physical activity, and strength-building habits. The other group will receive standard of care, a Fitbit device, resources for physical activity and nutrition, and the opportunity to participate in the lifestyle program at the completion of their 8-months in the study.

Participants will be assessed at the start of the study, after four months, and again at eight months. Throughout the study, the team will measure levels of physical activity using Fitbit devices. They will also evaluate overall diet quality using 24- hour dietary recalls of foods and beverages consumed. In addition, the team will examine other health and behavior measures, including intake of protein, fruits, and vegetables; participation in muscle-strengthening activities; confidence in maintaining healthy habits; muscle mass; body weight; waist circumference; and blood pressure.

In the 2nd Aim, the study team will evaluate implementation factors, such as how many participants were reached, how the program was implemented, engagement within the program, and how well how well the lifestyle coaching program can be delivered within real-world healthcare settings. Information will be gathered from patients, lifestyle change program leaders, healthcare providers, and healthcare systems. Data sources will include medical records, program records, and interviews.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

220

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

    • Massachusetts
      • Worcester, Massachusetts, Stany Zjednoczone, 01605
        • Rekrutacyjny
        • UMass Chan Medical School - Shaw Building
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  1. Began using a GLP-1 within the past 6 months
  2. Currently using GLP-1
  3. Plans to continue GLP-1 use
  4. GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor)
  5. BMI ≥27 kg/m2
  6. Age 18 years of age and older
  7. Speaks and reads English or Spanish
  8. Willing to enroll in a digital lifestyle intervention for 4-months
  9. Willing to wear a Fitbit for 8 months

Exclusion Criteria:

  1. Was taking a GLP-1 within the 2 months prior to the current GLP-1 start date
  2. Currently participating in a structured lifestyle change program (receiving structured guidance and counseling on physical activity, diet or weight loss)
  3. Currently pregnant
  4. Planning to become pregnant in the next year
  5. Active diagnosis of an eating disorder
  6. Active diagnosis of Schizophrenia or bipolar disorder
  7. Unable to walk without assistance/assistive device or have restricted walking
  8. Inability to understand the study and provide informed consent
  9. Any physical, cognitive, or psychiatric condition that poses a risk or interferes with their ability to participate at the discretion of the study PI (Co-Is: in consultation with PI or if acting as/standing in for PI)

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie podtrzymujące
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Digital Lifestyle Coaching Program

Participants randomized to the digital LCI arm will participate in a 4-month digital lifestyle intervention consisting of content modules about physical activity, nutrition, and GLP-1 support, nutrition and physical activity tracking, goal-setting, access to a health coach. They will receive a Fitbit and the same resources as the Standard of Care arm.

Participants will be enrolled for a 4-month program, in which they will use the Noom app to self-monitor their dietary intake/physical activity, be provided with coaching feedback throughout, and access educational module. Modules include behavior change specific to GLP-1, i.e. higher protein intake than what is prescribed in Noom Weight, Common challenges while taking GLP-1 medications, and weight loss medications and what to expect while taking them. They will also have access to the Muscle Defense program, which provides education on resistance training exercises to prevent muscle loss.

Brak interwencji: Standard Care

Participants in the standard of care arm will receive physical activity and nutrition resources, including those endorsed by the CDC and local resources within UMass Memorial Health and the surrounding communities, as well as Fitbit device. Upon completion of the 8-month study measures, participants will have the opportunity to participate in the 4-month digital LCI program, free of cost.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Primary Outcomes
Ramy czasowe: Baseline, 4-, and 8-months

Minutes of moderate/vigorous PA per day (over 7 days) assessed via Fitbits on days the participant has sufficient wear time, defined as >10 hours of heart rate data (accumulated of 60-second bouts).

Baseline, 4-, and 8-months
Healthy Eating Index
Ramy czasowe: Baseline, 4, and 8 months

Healthy Eating Index will be assessed via two 24-hour dietary recalls at each timepoint. The Healthy Eating Index is scored on a scale 0-100, with higher scores indicating better diet quality and alignment with the Dietary Guidelines for Americans.

Baseline, 4, and 8 months

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Physical Activity/Sedentary Time Metrics
Ramy czasowe: Mean counts over 7-days at baseline, 4-, and 8-months.

Objective metrics of mean step counts (steps/day), light physical activity (minutes/day), sedentary time (hours/day) over 7 days assessed via Fitbit Inspire using Fitbit algorithms and obtained through Fitabase.

Mean counts over 7-days at baseline, 4-, and 8-months.
Protein, Fruit, and Vegetable Intake
Ramy czasowe: Baseline, 4-, and 8-months

Proportion of daily intake values for each category will be assessed using two 24-hour dietary recalls.

Baseline, 4-, and 8-months
Lean Body Mass
Ramy czasowe: Baseline, 4-, and 8-months

Lean body mass will be assessed using a seca mBCA 554 bioelectrical impedance scale. The scale will obtain the results of the patient's body composition (% muscle mass, % water, % body fat, including areas of distribution).

Baseline, 4-, and 8-months
Body Weight
Ramy czasowe: Baseline, 4-, and 8-months

Body weight will be assessed via a seca mBCA 554 bioelectrical impedance scale.

Baseline, 4-, and 8-months
Blood Pressure
Ramy czasowe: Baseline, 4-, and 8-months

Three blood pressure readings will be taken 2 minutes apart after 5 minutes of rest using an automatic oscillometric device, Omron HEM-907. The average of the three readings will be recorded.

Baseline, 4-, and 8-months
Body Mass Index (BMI)
Ramy czasowe: Baseline, 4-, and 8-months

Obtained via two height measurements using a stadiometer and one weight measurement using a Seca scale, using the standard equation (Weight (lbs) x 703) / height (in)2

Baseline, 4-, and 8-months
Muscle Strengthening Activities
Ramy czasowe: Baseline, 4-, and 8-months

Assessed via self-report using the Muscle Strengthening Exercise Questionnaire Short Form, a scale assessing key dimensions of muscle-strengthening exercise, including frequency, session duration, intensity, exercise type, and muscle groups targeted

Baseline, 4-, and 8-months
Physical Activity Self-Efficacy
Ramy czasowe: Baseline, 4-, and 8-months

A self-report assessment using the Self-efficacy for Physical Activity Scale, a 5-question scale assessing how confident a person is that they could be physically active in certain situations

Baseline, 4-, and 8-months
Physical Activity Motivation
Ramy czasowe: Baseline, 4-, and 8-months

A self-report assessment using the 1 question Readiness to Change for Physical Activity, which assess a person's current physical activity habits and readiness to change.

Baseline, 4-, and 8-months
Healthy Eating Self-Efficacy
Ramy czasowe: Baseline, 4-, and 8-months

A self-report assessment using the Eating and Weight Self-efficacy Scale, a 7-question scale assessing a person's confidence to eat healthy in certain situations

Baseline, 4-, and 8-months
Healthy Eating Motivation
Ramy czasowe: Baseline, 4-, and 8-months

A self-report assessment using the 1 question Readiness to Change for Healthy Eating, which assess a person's current eating habits and readiness to change

Baseline, 4-, and 8-months
Global Physical Health
Ramy czasowe: Baseline, 4-, and 8-months

Physical health will be assessed using the PROMIS Global Physical Health, consisting of 4 questions asking about overall health, physical function, pain, and fatigue using Likert scale responses

Baseline, 4-, and 8-months
Intervention Acceptability
Ramy czasowe: 4-months in Intervention group only

The Theoretical Framework of Acceptability (TFA) is an 8-item questionnaire that can be adapted to an intervention to assess the acceptability of healthcare interventions using a Likert scale of 1 to 5 (higher scores indicating greater acceptability).

4-months in Intervention group only

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Jamie Faro, PhD, UMass Chan Medical School

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

22 lipca 2026

Zakończenie podstawowe (Szacowany)

30 kwietnia 2029

Ukończenie studiów (Szacowany)

29 września 2029

Daty rejestracji na studia

Pierwszy przesłany

13 marca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

13 marca 2026

Pierwszy wysłany (Rzeczywisty)

18 marca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

24 września 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

21 września 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

Participant survey data and participant physiologic data will be shared. This includes a complete, de-identified data set, including survey and clinical/physiologic data (and relevant R or SAS code) through DKnet, the Inter-University Consortium for Political and Social Research, or eScholarship@UMassChan.

Ramy czasowe udostępniania IPD

IPD and supporting information will become available at time of primary results publication.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA
  • SOK ROŚLINNY
  • ICF

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj